Effects of arginine-vasopressin fragment 4-9 on rodent cholinergic systems

Pharmacology Biochemistry and Behavior

Volumn 63, Issue 4, 1999, Pages 549-553

  Tanabe, Shuichi ^a   Shishido, Yoshiyuki ^a   Nakayama, Yasuhisa ^b   Furushiro, Masayoshi ^a   Hashimoto, Shusuke ^a   Terasaki, Tetsuya ^c   Tsujimoto, Gozoh ^b   Yokokura, Teruo ^a  

^a YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

^b NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

Author keywords

Acetylcholine release; Arginine vasopressin fragment 4 9; Hippocampal slice; Passive avoidance

Indexed keywords

ARGIPRESSIN[1 (3,3 CYCLOPENTAMETHYLENE 3 MERCAPTOPROPIONIC ACID) 2 (O METHYLTYROSINE)]; ARGIPRESSIN[4-9]; CALCIUM; POTASSIUM; SCOPOLAMINE; VASOPRESSIN ANTAGONIST; VASOPRESSIN DERIVATIVE; VASOPRESSIN V1 RECEPTOR;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DOSE RESPONSE; FACILITATION; HIPPOCAMPUS; IN VITRO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; LEARNING; MALE; MEMORY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TECHNIQUE; TEMPERATURE;

ACETYLCHOLINE; ANIMALS; ARGININE VASOPRESSIN; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; CALCIUM; HIPPOCAMPUS; LEARNING; MALE; MEMORY; MUSCARINIC ANTAGONISTS; PARASYMPATHETIC NERVOUS SYSTEM; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; RECEPTORS, VASOPRESSIN; SCOPOLAMINE; TEMPERATURE;

ANIMALIA; RODENTIA;

EID: 0032766765     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(99)00034-9     Document Type: Article

References (31)

1. Ader R., Weijnen J.A.W.M., Moleman P. Retention of a passive avoidance response as a function of the intensity and duration of electric shock. Psychon. Sci. 26:1972;125-128.
2. Bartus R.T., Dean R.L., Beer B., Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science. 217:1982;408-417.
3. 4-9, binding sites in brain. Distribution distinct from that of parent peptide Life Sci. 38:1986;443-452.
4. Burbach J.P.H., Kovács G.L., De Wied D., Van Nispen J.W., Greven H.M. A major metabolite of arginine vasopressin in the brain is highly potent neuropeptide. Science. 221:1983;1310-1312.
5. Burbach J.P.H., Lebouille J.L.M. Proteolytic conversion of arginine-vasopressin and oxytocin by brain synaptic membrane. J. Biol. Chem. 258:1983;1487-1494.
6. Costantini M.C., Pearlmutter A.F. Properties of specific binding site for arginine vasopressin in rat hippocampal synaptic membranes. J. Biol. Chem. 259:1984;11739-11745.
7. Damsma G., Lammerts V.B.D., Westerink B.H.C., Horn A.S. Determination of acetylcholine in the femtomole range by means of HPLC, a post-column enzyme reactor, and electrochemical detection. Chromatographia. 24:1987;827-831.
8. De Wied D., Gaffori O., Van Ree J.M., De Jong W. Central target for the behavioral effects of vasopressin neuropeptides. Nature. 308:1984;276-278.
9. De Wied D., Gaffori O., Burbach U.P.H., Kovács G.L., Van Ree J.M. Structure activity relationship studies with C-terminal fragments of vasopressin and oxytocin on avoidance behaviors of rats. J. Pharmacol. Exp. Ther. 241:1987;268-274.
10. 2+ in LLC-PK1 porcine kidney cells. Am. J. Physiol. 272:1997;C810-C817.
11. Du Y., Wu J., Jiang X., Gu Y. Characterization of binding sites of a memory-enhancing peptide AVP (4-8) in rats cortical synaptosomal membranes. Peptides. 15:1994;1273-1279.
12. Fahrenholz F., Jurzak M., Gerstberger R., Haase W. Renal and central vasopressin receptors. Immunocytochemical localization Ann. NY Acad. Sci. 689:1993;194-206.
13. Fujiwara M., Ohgami Y., Inada K., Iwasaki K. Effect of active fragments of arginine-vasopressin on the disturbance of spatial cognition in rats. Behav. Brain Res. 83:1997;91-96.
14. Gaffori O.J.W., De Wied D. Time-related memory effects of vasopressin analogues in rats. Pharmacol. Biochem. Behav. 25:1986;1125-1129.
15. Hirate K., Hirano M., Nakajima Y., Hiyama A., Maeda O., Asakura Y. No. 302 a newly synthesized [pGlu4, Cyt6] AVP (4-9) analogue, prevents the disruption of avoidance behavior. Behav. Brain Res. 83:1997;205-208.
16. Kinoshita K., Kawashima K., Kawashima Y., Fukuchi I., Yamamura M., Matsuoka Y. Effect of TA-0910, a novel thyrotropin-releasing hormone analog, on in vivo acetylcholine release and turnover in rats. Jpn. J. Pharmacol. 71:1996;139-145.
17. 1b vasopressin receptor gene. Proc. Natl. Acad. Sci. USA. 92:1995;6783-6787.
18. Maegawa H., Katsube N., Ogawa T., Aishita H., Kawasaki A. Arginine vasopressin fragment 4-9 stimulates the acetylcholine release in hippocampus of freely-moving rats. Life Sci. 51:1992;285-293.
19. Morris R.G.M.G., Rawlins J.N.P., O'Keef J. Place navigation impaired in rats with hippocampal lesions. Nature. 297:1982;681-683.
20. Olton D.S., Walken J.A., Gage F.H. Hippocampal connections and spatial discrimination. Brain Res. 139:1978;295-308.
21. Shishido Y., Furushiro M., Tanabe S., Nishiyama S., Hashimoto S., Ohno M., Yamamoto T., Watanabe S. ZTTA, a postproline cleaving enzyme inhibitor, improves cerebral ischemia-induced deficits in a three-panel runway task in rats. Pharmacol. Biochem. Behav. 55:1996;333-338.
22. 2+ and temperature independent components. Neurosci. Lett. 219:1996;159-162.
23. Strupp B.J. Improvement of memory by vasopressin fragment. Importance of individual differences in mnemonic function Behav. Neurochem. 103:1989;743-754.
24. Suzuki T., Fujimoto K., Oohata H., Kawashima K. Effects of TRH and DN147 on high potassium-evoked acetylcholine release from rat basal forebrain slices as determined directly by radioimmunoassay. Gen. Pharmacol. 20:1989;239-242.
25. Suzuki T., Nonaka H., Fujimoto K., Kawashima K. Effects of physostigmine and some nitric oxide-cyclic GMP-related compounds on muscarinic receptor-mediated autoinhibition of hippocampal acetylcholine release. J. Neurochem. 60:1993;2285-2289.
26. Suzuki T., Kanagawa M., Takada Y., Fujimoto K., Kawashima K. Nerve growth factor treatment induces high-potassium-evoked calcium-dependent acetyl-choline release in cultured embryonic rat septal cells. Brain Res. 665:1994;311-314.
27. 1a receptor in the CNS of male and female rats. Mol. Brain Res. 24:1994;1-10.
28. Tanabe S., Shishido Y., Furushiro M., Kado K., Hashimoto S., Yokokura T., Ohsawa T. Facilitation of passive avoidance response by newly synthesized cationized arginine vasopressin fragment 4-9 in rats. Pharmacol. Biochem. Behav. 57:1997;251-256.
29. Toide K., Iwaomoto Y., Fujiwara T., Abe H. JTP-489. A novel prolyl endopeptidase inhibitor with potential as a cognitive enhancer J. Pharmacol. Exp. Ther. 274:1995;1370-1378.
30. 2+ Pflügers Arch. Eur. J. Physiol. 433:1996;109-115.
31. 1a vasopressin receptor mRNA expression in cultured neurons, astroglia, and oligodendroglia of rat cerebral cortex. Mol. Brain Res. 45:1997;138-140.